Development of the human hypothalamus.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology.
PubMed 7643957 · doi:10.1007/BF01694533
What was done
Narrative review describing the structural, neurochemical, and functional development of human hypothalamic nuclei (including the suprachiasmatic nucleus, sexually dimorphic nucleus, supraoptic nucleus, and paraventricular nucleus) in normal physiology, sexual differentiation, birth, and developmental disorders.
What was found
The abstract reports that the sexually dimorphic nucleus (SDN/INAH-1) has only 20% of its cell number at birth, increases equally in both sexes until 2 to 4 years of age, and decreases thereafter in females, resulting in the SDN being twice as large in young adult males as in females, with no relation to male sexual orientation. Suprachiasmatic nucleus (SCN) vasopressin and VIP neurons develop mainly postnatally and exhibit sex differences in shape and cell counts. In the supraoptic and paraventricular nuclei, tyrosine hydroxylase colocalizes predominantly with vasopressin in neonates and with oxytocin in adults. Specific alterations in peptidergic, aminergic, and cholinergic transmitters are also noted in SIDS.
Why it matters
It synthesizes anatomical and endocrine timelines for human hypothalamic maturation, illustrating that significant structural sexual dimorphism arises postnatally.
Limits
This is a narrative review with no systematic search methodology reported. The abstract provides limited quantitative metrics and derives conclusions from postmortem observational data without detailing sample sizes or control characteristics.
Cited by
- supports In newborn humans, the suprachiasmatic nucleus is not yet fully developed or fully connected to the rest of the body.